SEC Reports
1
SM
SMNRW
Semnur Pharmaceuticals, Inc.
—
High Impact Filing (7/10) Biotech & Drug Discovery
Snapshot
The big-picture read on SMNRW right now — valuation, ownership and activity at a glance.
Price chart 30d -18.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
1 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 0 neutral · avg impact 7.0/10.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SMNRW.
Shares short
2,962
Settlement Sep 15, 2026
Change vs prior
0.0%
Semi-monthly cycle
Days to cover
2.2
At avg daily volume
All SMNRW filing & press-release reports (1)
- 8-K reportApr 23, 2026